Mode of action of anticancer agents on iron metabolism in tumor-bearing mice. II. A possible mechanism for potentiation of the carcinostatic activity of alkylating agents by ferrous glucuronate.
D000477:Alkylating Agents / Q000494:pharmacology*; D000818:Animals; D001205:Ascorbic Acid; D001375:Azaguanine / Q000494:pharmacology*; D002286:Carcinoma, Ehrlich Tumor / Q000378:metabolism*; D002614:Chelating Agents / Q000378:metabolism; D005965:Glucuronates / Q000378:metabolism; D006836:Hydro-Lyases; D007408:Intestinal Absorption / Q000187:drug effects; D007501:Iron / Q000378:metabolism*; D015122:Mercaptopurine / Q000494:pharmacology*; D051379:Mice; D011166:Porphyrins / Q000378:metabolism; D011809:Quinones / Q000494:pharmacology; D013852:Thiotepa / Q000494:pharmacology*
D000477:Alkylating Agents; D002614:Chelating Agents; D005965:Glucuronates; D011166:Porphyrins; D011809:Quinones; D013852:Thiotepa; D007501:Iron; D015122:Mercaptopurine; D006836:Hydro-Lyases; D001205:Ascorbic Acid; D001375:Azaguanine